Screener
Amylyx Pharmaceuticals, Inc. AMLX Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$43.42M-4.8% | -$41.28M-15.0% | -$33M+12.1% | -$34.39M+52.7% | -$41.44M+43.0% | ||
| $43K-69.5% | $98K-37.2% | $108K-32.5% | $120K-45.7% | $141K-32.2% | ||
| $8.32M+13.2% | $6.12M-10.4% | $6.39M-5.3% | $7.08M+4.0% | $7.35M-23.2% | ||
| -$31.42M-24.5% | -$36.88M+7.4% | -$27.9M+52.7% | -$30.37M+26.9% | -$25.25M+62.1% | ||
| —— | —— | $86K+330% | $24K— | $17K-80.9% | ||
| -$149.8M— | $36.26M+183% | $29.47M-54.7% | —— | —— | ||
| —— | —— | —— | $191.11M— | —— | ||
| $1.48M— | $3.22M-95.1% | —— | $191.61M+239,407% | —— | ||
| -$179.81M-10,622% | $2.49M+114% | $1.48M— | $166.63M+6,934% | -$1.68M+98.2% |
FAQ
- How much cash does Amylyx Pharmaceuticals, Inc. generate?
- Amylyx Pharmaceuticals, Inc. (AMLX) generated -$126.6M in operating cash flow over the trailing twelve months.
- Where does Amylyx Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amylyx Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.